The legislature's own summary of the bill, or its official long title.
Currently, all health insurance plans subject to requirements under Delaware law must include at least 1 formulation of epinephrine autoinjectors on the lowest tier of the carrier's drug formulary for individuals who are 18 years of age or younger. This Act expands this requirement to all covered individuals, regardless of age, by January 1, 2024. This Act also makes a technical correction to §§ 3571Y of Title 18 to add standard language about applicability, which is already in § 3370D of Title 18.
Every action
7 steps, oldest first, as the legislature records them.
CommitteeIntroduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House · House Economic Development/Banking/Insurance & Commerce
CommitteeReported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 7 Favorable, 5 On Its Merits · House Economic Development/Banking/Insurance & Commerce
HousePassed By House. Votes: 39 YES 2 ABSENT39–0 vote
CommitteeAssigned to Banking, Business, Insurance & Technology Committee in Senate · Senate Banking, Business, Insurance & Technology
CommitteeReported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 3 Favorable, 3 On Its Merits · Senate Banking, Business, Insurance & Technology
SenatePassed By Senate. Votes: 20 YES 1 NO20–1 vote
GovernorSigned by Governor
Roll calls
2 recorded votes: 2 on the floor, 0 in committee. Each shows how every member voted.
Passed By House. Votes: 39 YES 2 ABSENT · Full House